Histopathologic Findings Described for MERS-CoV Autopsy

This article originally appeared here.
Share this content:
Histopathologic Findings Described for MERS-CoV Autopsy
Histopathologic Findings Described for MERS-CoV Autopsy

FRIDAY, Feb. 5, 2016 (HealthDay News) -- The main histopathologic findings of Middle East respiratory syndrome coronavirus (MERS-CoV) infection are diffuse alveolar damage in the lungs and evidence of chronic disease in other organs, according to research published online Feb. 5 in The American Journal of Pathology.

Dianna L. Ng., from the U.S. Centers for Disease Control and Prevention in Atlanta, and colleagues describe the histopathologic, immunohistochemical, and ultrastructural findings from the first autopsy performed on a fatal case of MERS-CoV. The fatality was related to a hospital outbreak in the United Arab Emirates in April 2014.

The researchers note that diffuse alveolar damage was the main histopathologic finding in the lungs. In other organs there was evidence of chronic disease, including severe peripheral vascular disease, patchy cardiac fibrosis, and hepatic steatosis. Pneumocytes and epithelial syncytial cells were identified as important targets of MERS-CoV antigen in double staining immunoassays that used anti-MERS-CoV antibodies paired with immunohistochemistry for cytokeratin and surfactant. Colocalization in scattered pneumocytes and syncytial cells was seen in double immunostaining with dipeptidyl peptidase 4. There was no evidence of extrapulmonary MERS-CoV antigens, including in the kidney.

"These results provide critical insights into the pathogenesis of MERS-CoV in humans," the authors write.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »